Drug Approval | May 06, 2023
Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India
The interaction with key Government Officials and industry leaders led to a joint exploration of possible collaboration and investments in the Healthcare ecosystem between the two countries
The acquisition is a crucial step in LTS' strategy to broaden its portfolio of drug delivery platforms.
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
Affordability is key to providing accessible healthcare for Bharat.
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
Carbidopa and Levodopa is used to treat symptoms of Parkinson's disease or Parkinson-like symptoms
Acetazolamide is used to treat glaucoma
Subscribe To Our Newsletter & Stay Updated
